Effect of burdensome symptoms on treatment preferences of patients with PsAMarch 24, 2022Psoriatic Arthritis
Secukinumab shows a satisfactory retention rate in PsA in real-world settingMarch 24, 2022Psoriatic Arthritis
Degree of disease control influences abnormalities in renal parameters in PsAMarch 24, 2022Psoriatic Arthritis
Degree of disease control influences abnormalities in renal parameters in PsAMarch 24, 2022Psoriatic Arthritis
Scoring by MRI is an effective way to identify change in clinical outcomes of PsAMarch 24, 2022Psoriatic Arthritis
Reduced humoral response to SARS-CoV-2 vaccine in patients receiving systemic therapy for PsAMarch 24, 2022Psoriatic Arthritis
PsA: Comparable efficacy, safety, and persistence with TNFi or ustekinumab in real worldMarch 24, 2022Psoriatic Arthritis
PsA: Methotrexate+leflunomide more effective but less well tolerated than methotrexate monotherapyMarch 24, 2022Psoriatic Arthritis
Introducing adalimumab vs. escalating methotrexate in patients with inadequately controlled PsAMarch 24, 2022Psoriatic Arthritis
Rheumatology NewsNatural, vaccine-induced, and hybrid immunity to COVID-19March 23, 2022COVID-19 Updates
Rheumatology News‘Profound implications’: COVID ups diabetes risk 40% a year laterMarch 23, 2022COVID-19 UpdatesLong COVID
Rheumatology NewsYes, Russian docs should be shut out of medical associations, says ethicistMarch 22, 2022Mixed Topics
Rheumatology NewsU.S. health officials tracking COVID-19 increase in U.K.March 22, 2022COVID-19 Updates
Rheumatology NewsTrial gives new guidance for choosing initial PsA treatmentMarch 22, 2022Psoriatic Arthritis
